COVID-19 T-cell Data: Mapping out SARS-CoV-2 Antigen and T-cell Repertoires

What you will learn in this webinar

In partnership with Microsoft, Adaptive Biotechnologies has created a comprehensive and detailed open access database, ImmuneCODE, that provides COVID-19 data to accelerate ongoing efforts to develop better diagnostics, vaccines, and therapeutics for COVID-19. Here we will discuss the science behind the ImmuneCODE database presented in Nolan et al, some of the applications for which you can analyze the data, use of the immunoSEQ T-MAP COVID service, and initial data insights from the COVID-19 data described in Snyder et al.

1 - T cells in COVID-19 (Speaker Image) Patrick_Raber_Headshot_150

Patrick Raber Ph.D

Sr. Research & Business Development Manager
ThomasSnyderHeadshot-cropped-sq

Thomas Snyder, Ph.D

VP, Research, immunoSEQ Dx, Adaptive Biotechnologies
Sean-Nolan

Sean Nolan

Distinguished
Engineer

Register for SEQdiscovery

To access these videos and all SEQdiscovery content.
If you have previously registered and opted to have an account please log in above.